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Abstract
Background
Healthcare organizations are making the transition from volume to value-based care, thus relying
on standardized performance measures for quality improvement. Some challenges of this
strategy include the following: ambiguity and inconsistency of metric definitions across
reporting systems, a dearth of measures that are representative of clinical care and patient
experience, and unfair or inappropriate comparisons of organizations serving patients exposed to
different sociodemographic risk factors.
Rationale
Developing and evaluating a clinical quality scorecard that is internal to a federally qualified
health center will provide insight into its value-based performance. It will also allow for efficient
improvement in clinical care and patient experience as well as data transparency among health
care providers. The goal of the current project was to develop one such clinical quality scorecard
for implementation at Cornell Scott-Hill Health Center (CS-HHC).
Method
Quality indices were compiled from a list of standardized performance measures included in the
health care initiatives of CS-HHC. The scorecard was implemented in September 2018, and
measures taken before and after implementation were compared. Primary outcomes included
patient outcomes (physical measures such as diabetic hemoglobin A1c and blood pressure levels)
as well as clinic endpoints (overall quality of care and likelihood of recommending clinic).
Specific time points for selected metrics were plotted into line graphs to allow visual analysis
over time and monthly progress reports were distributed to department leaders of CS-HHC.
Analysis for the current study was limited to measures that are administered to the health center
on a monthly basis. Metrics were evaluated 3-months prior to scorecard implementation, and
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were compared to outcomes measured 3-months after scorecard distribution. A cross-sectional
survey was administered at baseline and 5-months following scorecard implementation to assess
changes in comprehension of metrics among medical directors.
Results
Visual inspection of the line graphs suggested improvement from baseline to post-scorecard
implementation in the following measures of patient outcomes: HIV viral load suppression, CD4
monitoring, lipid screening, hepatitis B vaccination and diabetic low density lipoprotein levels.
However, these changes did not reach statistical significance when evaluated with unpaired
students’ t-tests. Questionnaire item responses show an improvement in medical directors’
comprehension of clinical quality measures from baseline to follow-up; the mean scores for each
item were descriptively higher after 5 months of scorecard distribution than at baseline.
Conclusions
The development and evaluation of a clinical quality scorecard suggests that improvement in
clinical care, patient experience and data transparency is feasible within a federally qualified
health center. Future research should utilize a longitudinal intervention design to explore
possible trends in health center performance metrics and analyze medical directors’
comprehension of clinical quality measures.
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Introduction
It is widely known that the US healthcare system is fragmented and decentralized by design.
Historically, the volume of health services delivered has been the key driver of performance
within health care delivery organizations. Fortunately, healthcare institutions are making the
transition from volume to value-based care (Austin et al. 2015; Porter et al. 2016). For the sake
of quality improvement, health care organizations adhere to a number of standardized
performance measures with respect to patient outcomes, such as good control of diabetes and
avoidance of antibiotics in adults with acute bronchitis. Metric definitions, however, can be
ambiguous and inconsistent across reporting systems. In addition, not all measures truly
represent quality in clinical care and patient experience (Casalino et al. 2016). Research shows
that less than 30% of physician practices deemed current metrics to be moderately representative
of quality care (Casalino et al. 2016).
Difficulties also arise when using these quality measures to compare health care providers that
serve patients exposed to distinct sociodemographic risk factors. Organizations serving
disadvantaged populations may be misclassified as ‘low quality’ based on unadjusted outcome
measures whereas centers providing care to wealthy clients may be ranked higher in quality
metrics (Burstin et al. 2016 ; Fiscella et al. 2014). Therefore, health care organizations serving
low income populations need to be especially aware of their performance on clinical quality
measures in order to effectively target clinical quality improvement efforts. The current project
aims to addresses this issue through the development of an internal quality scorecard for a
federally qualified health center. Health care institutions utilize scorecards to track performance
in health services, clinical care and patient satisfaction (Austin et al. 2015). The scorecard
incorporates and defines measures that medical directors consider to be determinants of quality
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in various clinical departments and the organization as a whole. The input of health professionals
is essential for consolidating the quality metrics which truly matter for health center performance
and population health. An internal scorecard also eliminates the problems created by external
comparisons that do not account for patient sociodemographic risk factors, and allows the
organization to identify areas of progress and areas in need of more intensive focus. A clinical
quality scorecard that is internal to a federally qualified health center and relevant across clinical
departments can allow for efficient improvement in clinical care, patient experience and data
transparency (Dehmer et al. 2014).
The aim of this project was to implement a clinical quality scorecard at a federally qualified
health center as a means to identify high priority quality performance metrics, and to spur
improvement in clinical care and patient experience. In order to achieve this aim, a scorecard
was constructed for Cornell Scott-Hill Health Center (CS-HHC). CS-HHC is a multi-site multispecialty organization that provides affordable care to underserved populations in the Greater
New Haven area. The scorecard consists of quality metrics that are deemed a priority by various
departments at CS-HHC.
Specific measures were utilized as a proxy for improvement in clinical care and patient
experience (i.e. overall quality of care, hepatitis B vaccination among patients with HIV and
diabetes composite metrics). Collaboration with medical leadership occurred to distribute the
scorecard to department leaders on the monthly basis; data transparency is necessary for efficient
allocation of resources and attention (Dehmer et al. 2014; Lindenauer et al. 2014). Pre- and postdata for the specified outcome measures were collected and analyzed in the span of six months.
In addition, a questionnaire was developed and administered to evaluate awareness of key quality
measures amongst department leaders. It is hypothesized that scorecard users will have increased
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awareness of organizational performance on important clinical quality measures, and that
ultimately the use of the scorecard will result in improvements in clinical care and patient
outcomes.
Methods
Development
Quality measures were compiled from a list of standardized performance measures included in
the following health care initiatives at CS-HHC: Patient Centered Medical Home Plus (PCMH+),
Practice Transformation Network (PTN) and Uniform Data System (UDS). Quality measures
with their corresponding definitions were compiled in Microsoft Excel and sorted by area of
clinical relevance (e.g. Adult Medicine, Pediatrics, Women’s Health, Infectious Disease, Dental,
Behavioral Health, or Organization-wide). Meetings were conducted with medical directors and
representatives of each department to discuss key measures that are in need of improvement or
ranked as a priority for performance tracking for their clinical area. The clinical quality scorecard
was developed and included one to five quality measures for each department, as well as several
high-priority measures chosen for the entire organization. Data for selected metrics were
obtained from the following sources: CT Medicaid CareAnalyzer, PRCEasyView, HRSA, i2i
and OPCC. Currently available data were merged into a single database (in Excel) and specific
time points for measurements were plotted into line graphs to allow visual analysis over time.
Brief measure definitions were included in a “Legend” by each graph. A full list of patient
metrics appears in Appendix A. The scorecard appears in Appendix B. Appendix C contains the
patient experience survey and the medical provider questionnaire appears in Appendix D.
Evaluation
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Clinical care and patient experience were evaluated via multiple metrics. Several of the key
metrics are available only as 12-month rolling statistics or only with a 3-month delay due to
medical claims lag, so analysis for the current study was limited only to measures that are
reported monthly without a lag period. These included: patient experience (e.g. rating of overall
quality of care and likelihood of recommending clinic); infectious disease (e.g. viral load
suppression, CD4 monitoring, lipid screening and hepatitis B vaccination); diabetes control (e.g.
hemoglobin A1c, low density lipoprotein level and blood pressure). Primary measures were
evaluated prior to implementation of the scorecard and were compared to outcomes measured
after implementation of the scorecard. Data analysis was performed using SAS statistical
software. Monthly progress reports were generated from scorecard data and disseminated to
medical directors of CS-HHC. A pre- and post-implementation survey was developed to assess
awareness among medical leadership of the key quality measures contained in the scorecard. The
questionnaire was administered online and consists of 5 questions in the six-point Likert scale
format, which includes strongly disagree, disagree, somewhat disagree, somewhat agree, agree
and strongly agree (see Appendix D). The even number of item responses allows for easier
grouping into an unfavorable or favorable category.
Data Analysis
For the ‘Patient Experience’ measures (Appendix C), mean scores and standard deviations were
calculated at baseline and post-implementation. For the purpose of this study, baseline is a
weighted average of data collected during the 3 months prior to scorecard distribution; postimplementation refers to the weighted average of data gathered 3 months after the scorecard has
been introduced to the center. Since data were not matched, independent samples before and
after implementation was assumed. An independent t-test was used to examine a significant

8
difference in mean scores before and after implementation. For the remaining scorecard metrics
with categorical outcomes, a chi-square goodness of fit test was conducted to compare observed
values at post-implementation and expected values from baseline. Statistical significance in the
analyses was based on an alpha of 0.05.
With respect to the medical provider survey administered at baseline and 5-month follow-up,
higher scores represented increased understanding of clinical quality measures. Mean scores of
each item were calculated; a statistical analysis could not be performed because survey responses
were anonymous and thus not matched in the study. The survey completion rate at baseline and
5-month follow-up was 100%. The response rate was 76.5% for the baseline survey with a
potential reach of 17 people; the follow-up survey had a response rate of 88.9% with a potential
reach of 18 individuals. Figure 4 and Figure 5 show the distribution of item responses among
medical directors at CSHHC before scorecard implementation and at 5-month follow-up,
respectively.
Results
Patient Experience Metrics
Overall Quality of Care
Descriptively, the weighted mean score at post-implementation (M= 4.22, SD= 0.898) was lower
than baseline (M=4.32, SD=0.897). However, there was no significant difference between mean
scores at baseline and post-scorecard t(621) =1.29 , p=0.199. A score of ‘5’ means Excellent.
Likelihood of Recommending Clinic
The weighted mean score at post-implementation (M=4.23, SD=0.898) was descriptively less
than baseline (M=4.29, SD=0.924). This difference is not significant between baseline and postscorecard mean scores t(619) =0.93, p=0.354. A score of ‘5’ means Excellent.
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Infectious Disease Metrics
Viral Load Suppression
Descriptively, the proportion of HIV patients who achieved viral load suppression was higher at
post-implementation (84.6%) as compared to baseline (81.8%). A chi-square goodness-of-fit test
indicates there was no significant difference, χ2 (1, n=244) = 0.52, p= 0.471.
CD4 Monitoring
The proportion of HIV patients who had 2 or more CD4 counts performed at least 3 months apart
was descriptively higher at post-implementation (68.3%) than baseline (67.3%). However, this
difference was not significant, χ2 (1, n=230) = 0.05, p= 0.828.
Lipid Screening
Descriptively, the proportion of HIV patients prescribed HIV antiretroviral therapy and had
fasting lipid panel was higher at post-implementation (71.8%) as compared to baseline (70.5%).
A chi-square goodness-of-fit test indicates there was no significant difference, χ2 (1, n=209) =
0.09, p= 0.762.
Hepatitis B Vaccination
The proportion of HIV patients with completed vaccination series over the past 12 months was
descriptively higher at post-implementation (78.8%) than baseline (75.3%). However, this
difference was not significant, χ2 (1, n=94) = 0.68, p= 0.409.
Adult Medicine Metrics
Diabetes Control
Descriptively, the proportion of patients with good control of their diabetes was lower at postimplementation (21.0%) as compared to baseline (23.7%). A chi-square goodness-of-fit test
indicates there was no significant difference, χ2 (1, n=626) = 0.40, p= 0.526.
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Hemoglobin A1C (HbA1c)
The proportion of patients with last HbA1c test less than 8.0 over the past 12 months was
descriptively lower at post-implementation (55.6%) than baseline (56.9%). However, this
difference was not significant, χ2 (1, n= 626) = 0.04, p= 0.850.
Low Density Lipoprotein (LDL)
Descriptively, the proportion of patients with last LDL test less than 100 in the past 12 months
was higher at post-implementation (46.0%) as compared to baseline (45.5%). A chi-square
goodness-of-fit test indicates there was no significant difference, χ2 (1, n= 626) = 0.01, p= 0.917
Blood Pressure (BP)
The proportion of patients with last BP test less than 140/90 in the past 12 months was
descriptively lower at post-implementation (70.3%) than baseline (73.8%). However, this
difference was not significant, χ2 (1, n=626) = 0.63, p= 0.429.
Comprehension of Clinical Quality Measures
The medical provider survey contained 5 items (Appendix D). These questions were
administered on a 6 point Likert scale ranging from unfavorable to favorable understanding of
clinical quality metrics. As shown in Figure 4 and Figure 5, the mean scores of each item were
descriptively higher at post-scorecard implementation than baseline.
Table 1 shows the distribution of opinions toward comprehension of clinical quality measures.
Since questionnaires were administered anonymously, it is not possible to match provider
responses before and after scorecard implementation, thus precluding the ability to test for
statistical differences. Nevertheless, the data are reported here for descriptive purposes. At the 5month follow-up, 93.8% (N=15) of medical directors agreed or strongly agreed that they were
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aware of quality measures most important to their department at CSHHC compared to 84.6%
(N=11) at baseline. When asked about awareness of quality measures that are most important to
other departments at CSHHC, 50.0% (N=8) of medical directors responded strongly agree or
agree at follow-up in comparison to 38.5% (N=5) before scorecard distribution. At the 5-month
follow-up, 75.0% (N=12) of medical directors agreed or strongly agreed that they understand the
definitions of quality measures most important to CSHHC compared to 69.2% (N=9) at baseline.
When asked about awareness of their department’s performance on important clinical quality
measures, 75.0% (N=12) of medical directors responded strongly agree or agree at follow-up in
comparison to 69.2% (N=9) at baseline. Lastly, 56.3% (N=9) of medical directors at follow-up
strongly agree or agree that they are aware of CSHHC’s overall performance on important
clinical quality measures as compared to 23.1% (N=3) before scorecard distribution.
Discussion
The purpose of this study was to develop and evaluate a clinical quality scorecard at a federally
qualified health center as a means to improve clinical care and patient experience. Another aim
of this investigation was to create an internal scorecard that increases data transparency and
comprehension of quality metrics among medical directors. Since health care organizations are
transitioning from a volume to value-based approach in care, scorecards are beneficial for
monitoring performance in health services, patient satisfaction and clinical care (Austin et al.
2015, Porter et al. 2016). The construction of a scorecard for Cornell Scott-Hill Health Center
(CS-HHC) relied on collecting performance measures from multiple reporting systems and
clearly displaying measure definitions to remove ambiguity. Collaboration with medical
directors at CSHHC guided the consolidation process of metrics and enhanced awareness of
clinical quality measures that were in need of improvement. The evaluation of the scorecard was
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two-fold: independent t-tests and chi-square goodness of fit were utilized to determine a
significant difference in measures from baseline to 3-month post-implementation; a medical
provider survey administered before scorecard distribution and at 5-month follow-up examined
comprehension of metrics deemed important by the entire health center and individual
departments.
Descriptively, there was improvement from baseline to post-scorecard implementation in the
following measures: viral load suppression, CD4 monitoring, lipid screening, hepatitis B
vaccination and diabetic low density lipoprotein levels. However, the observed values of these
quality metrics were not statistically different from expected values. This result suggests that a
positive change in measures was likely due to chance. The remaining metrics included in the
study showed a decline from baseline to post-implementation of the scorecard. Likewise, this
difference was not statistically significant and most likely attributed to chance.
Questionnaire item responses descriptively show an improvement in medical directors’
comprehension of clinical quality measures from baseline to follow-up. Higher mean scores after
5 months of scorecard distribution suggests a greater percentage of medical directors became
more aware of quality measures that are not only important to their specific department, but also
other departments within CSHHC. The survey results also suggest that a greater proportion of
medical directors show an increased awareness of department performance on important quality
measures and that of the entire organization. Lastly, the observed trend of increase in mean
scores indicates a better understanding of quality measure definitions among medical directors at
CSHHC, although this trend did not achieve statistical significance.
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Limitations
A limitation of the present study was the lag of quality metric data available to CSHHC. The
measures included in this investigation had a 3-month lag or less, though many metrics present in
the quality scorecard had a lag period ranging from 4 -12 months, precluding their inclusion in
this analysis. Additionally, there were a limited number of months for which data was available
pre- and post-implementation, thus restricting the evaluation of scorecard impact on the quality
metrics performance. Current research suggests that not all standardized performance measures
are representative of quality (Casalino 2016). In order to prevent this form of inaccuracy in rating
performance, a phase of scorecard development incorporated the knowledge of medical directors
to gauge which measures are determinants of quality in their respective clinical departments and
the entire organization. Therefore, it was anticipated that the measures selected for statistical
analysis were an accurate representation of the quality of healthcare delivery at CSHHC.
Additionally, the study period was short in duration. Data were collected during the 3 months
prior to and after scorecard distribution; quality metrics consisted of patient outcomes and clinic
endpoints that take several months to achieve measurable improvement. Given this, the results of
the current study reflected no significant change from baseline to post-implementation for all
measures. A longitudinal intervention is needed to adequately assess the impact of a scorecard on
clinical quality measures.
Another limitation of the intervention-like study was the exclusion of an additional health center
to serve as a control group. The quality scorecard was an internal project which included
measures deemed necessary for performance tracking on behalf of CSHHC medical directors. A
within-group comparison of pre- and post-implementation data avoids misclassification of
quality based on unadjusted outcome measures (Fiscella 2014). However, CSHHC was involved
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in various health care initiatives throughout the study period, which could have influenced
changes seen in quality outcomes. Without a control group, it is difficult to address this form of
confounding and in turn, evaluate the effects of the scorecard alone on clinical care and patient
experience.
Lastly, the seasonality of patient groups throughout the study period introduced the possibility of
assessing different populations at baseline and post-implementation of the scorecard, which is an
inequivalent comparison. The baseline time period included June through August; post-scorecard
months were October through December. The current investigation was unable to account for
seasonal trends in performance measures due to its limited duration. A longitudinal study design
would allow for a better assessment of quality metrics between the same time periods at
subsequent years.
Future Research
Future research should conduct a longitudinal intervention study that examines a change in
metrics across several years of scorecard distribution. The present investigation tracked
performance in quality measures for a short duration, which limited the number of data points
collected during pre- and post-implementation of the scorecard. A long-term investigation period
would address the lag in data dispersal from multiple reporting tools to a federally qualified
health center. This strategy would also allow for an analysis of possible trends in health center
performance metrics. Additionally, a longitudinal intervention study would be able to
incorporate a large set of metrics that are representative of clinical quality; the study design
would take into account the lag in data dispersal that normally limits the number of measures that
can be assessed for tracking change in clinical care and patient experience. Lastly, the inclusion
of an additional health center as a control group would help move this research forward; a
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between-group comparison of organizations that serve populations with similar
sociodemographic risk factors would mitigate potential confounders, such as involvement in
concurrent health care initiatives.
Despite its limitations, this study provides the groundwork for developing and evaluating a
clinical quality scorecard that improves clinical care, patient experience and data transparency
within a federally qualified health center.
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Appendices
Figure 1. Changes in Patient Experience Metrics from Baseline to 3 months (score of ‘5’ is
Excellent, ‘1’ is Poor)

Figure 2. Changes in Infectious Disease Metrics from Baseline to 3 months (% of patients
meeting metric)
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Figure 3. Changes in Adult Medicine Metrics from Baseline to 3 months (% of patients meeting
metric)

Table 1. Distribution of opinions about awareness of clinical quality measures
Agree or Strongly Agree, n(%)

Survey item

Baseline, N=13

5-Month Follow-up, N=16

I am aware of quality measures most important
to my department at CSHHC

11 (84.6)

15 (93.8)

I am aware of quality measures most important
to other departments at CSHHC

5 (38.5)

8 (50.0)

I understand the definitions of quality measures
that are important to CSHHC

9 (69.2)

12 (75.0)

I am aware of my department’s performance on
important clinical quality measures

9 (69.2)

12 (75.0)

I am aware of CSHHC’s overall performance on
important clinical quality measures

3 (23.1)

9 (56.3)
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Figure 4.

Figure 5.
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APPENDIX A: Measure Definitions
Patient Experience - Overall Quality of Care
Percentage of patients who rated overall quality of care of CSHHC as 'excellent'*
Patient Experience - Likelihood of Recommending Clinic
Percentage of patients who rated likelihood of recommending clinic to friends/relatives as
'excellent'*
*Five Levels of Patient Experience: Excellent, Very Good, Good, Fair and Poor

Viral Load Suppression
Percentage of HIV patients with viral load less than 200 copies/ml at last test over the past 12
months.
CD4 Monitoring
Percentage of HIV patients with 2 or more CD4 counts performed at least 3 months apart over
the past 12 months.
Lipid Screening
Percentage of HIV patients prescribed HIV antiretroviral therapy and had fasting lipid panel over
the past 12 months.
Hepatitis B Vaccination
Percentage of HIV patients with completed vaccination series over the past 12 months.
Diabetes Control
Percentage of patients 18-75 years old with diabetes mellitus, 2 or more primary care visits with
diabetes mellitus codes in last 2 years, 1 or more visit in last 12 months and met the following in
past 12 months: last HbA1c less than 8.0, last LDL less than 100, last BP less than 140/90;
composite = meeting all 3; higher is better
Diabetes Control Sub-Measures
Hemoglobin A1C (HbA1c)
Percentage of patients with last HbA1c test less than 8.0 in the past 12 months.
Low Density Lipoprotein (LDL)
Percentage of patients with last LDL test less than 100 in the past 12 months.
Blood Pressure (BP)
Percentage of patients with last BP test less than 140/90 in the past 12 months.
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APPENDIX B: Clinical Quality Scorecard

Overall
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Cost of Care

23

Adult Medicine

24

Pediatrics

25

Women’s Health

26

Infectious Disease
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APPENDIX C: CSHHC Patient Experience Survey

Q1 Would you say the likelihood of your recommending [name of health clinic] to friends and
relatives is:

o Excellent
o Very Good
o Good
o Fair
o Poor
Q2 Overall, would you rate the quality of care provided as:

o Excellent
o Very Good
o Good
o Fair
o Poor
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APPENDIX D: CSHHC Quality Measures Survey

Q1 I am aware of the quality measures that are most important to my department at CSHHC.

o Strongly Disagree
o Disagree
o Somewhat Disagree
o Somewhat Agree
o Agree
o Strongly Agree
Q2 I am aware of the quality measures that are most important to other departments at CSHHC.

o Strongly Disagree
o Disagree
o Somewhat Disagree
o Somewhat Agree
o Agree
o Strongly Agree
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Q3 I understand the definitions of quality measures that are important to CSHHC.

o Strongly Disagree
o Disagree
o Somewhat Disagree
o Somewhat Agree
o Agree
o Strongly Agree
Q4 I am aware of my department's performance on important clinical quality measures.

o Strongly Disagree
o Disagree
o Somewhat Disagree
o Somewhat Agree
o Agree
o Strongly Agree
Q5 I am aware of CSHHC's overall performance on important clinical quality measures.

o Strongly Disagree
o Disagree
o Somewhat Disagree
o Somewhat Agree
o Agree
o Strongly Agree

